JP2002515423A - プログラム放出性及びパルス放出性の多微粒子薬剤形態、及びその調製方法 - Google Patents

プログラム放出性及びパルス放出性の多微粒子薬剤形態、及びその調製方法

Info

Publication number
JP2002515423A
JP2002515423A JP2000549222A JP2000549222A JP2002515423A JP 2002515423 A JP2002515423 A JP 2002515423A JP 2000549222 A JP2000549222 A JP 2000549222A JP 2000549222 A JP2000549222 A JP 2000549222A JP 2002515423 A JP2002515423 A JP 2002515423A
Authority
JP
Japan
Prior art keywords
polymer
active ingredient
water
coating
pharmaceutical form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000549222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515423A5 (enExample
Inventor
エドゥアール・ジェンドロ
ジェラール・クサン
フランソワーズ・ラゴ
マリー−クリスティーヌ・クリー−ブヴェ
Original Assignee
ラボラトワール・プログラファルム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラボラトワール・プログラファルム filed Critical ラボラトワール・プログラファルム
Publication of JP2002515423A publication Critical patent/JP2002515423A/ja
Publication of JP2002515423A5 publication Critical patent/JP2002515423A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000549222A 1998-05-20 1999-05-20 プログラム放出性及びパルス放出性の多微粒子薬剤形態、及びその調製方法 Pending JP2002515423A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/06384 1998-05-20
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (2)

Publication Number Publication Date
JP2002515423A true JP2002515423A (ja) 2002-05-28
JP2002515423A5 JP2002515423A5 (enExample) 2009-12-17

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000549222A Pending JP2002515423A (ja) 1998-05-20 1999-05-20 プログラム放出性及びパルス放出性の多微粒子薬剤形態、及びその調製方法

Country Status (24)

Country Link
EP (1) EP1077687B1 (enExample)
JP (1) JP2002515423A (enExample)
KR (1) KR100583065B1 (enExample)
CN (1) CN1186014C (enExample)
AT (1) ATE214598T1 (enExample)
AU (1) AU758299B2 (enExample)
BG (1) BG64764B1 (enExample)
BR (1) BR9910606A (enExample)
CA (1) CA2333188C (enExample)
DE (1) DE69901062T2 (enExample)
DK (1) DK1077687T3 (enExample)
ES (1) ES2173739T3 (enExample)
FR (1) FR2778848B1 (enExample)
GE (1) GEP20022750B (enExample)
HU (1) HU224193B1 (enExample)
IL (1) IL139774A (enExample)
MX (1) MXPA00011364A (enExample)
NO (1) NO330501B1 (enExample)
NZ (1) NZ508392A (enExample)
PL (1) PL192950B1 (enExample)
PT (1) PT1077687E (enExample)
TR (1) TR200100107T2 (enExample)
WO (1) WO1999059557A1 (enExample)
ZA (1) ZA200006768B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
ATE214598T1 (de) 2002-04-15
BG104963A (en) 2001-07-31
DK1077687T3 (da) 2002-06-17
FR2778848A1 (fr) 1999-11-26
MXPA00011364A (es) 2008-09-09
NO330501B1 (no) 2011-05-02
HUP0102027A2 (hu) 2002-03-28
AU3830299A (en) 1999-12-06
DE69901062T2 (de) 2002-10-31
GEP20022750B (en) 2002-08-26
TR200100107T2 (tr) 2001-06-21
KR20010052370A (ko) 2001-06-25
HU224193B1 (hu) 2005-06-28
IL139774A0 (en) 2002-02-10
BG64764B1 (bg) 2006-03-31
AU758299B2 (en) 2003-03-20
CN1186014C (zh) 2005-01-26
HUP0102027A3 (en) 2002-12-28
NZ508392A (en) 2002-09-27
PL192950B1 (pl) 2006-12-29
PL344314A1 (en) 2001-10-22
FR2778848B1 (fr) 2001-11-23
IL139774A (en) 2005-09-25
KR100583065B1 (ko) 2006-06-08
BR9910606A (pt) 2001-10-02
EP1077687B1 (fr) 2002-03-20
DE69901062D1 (de) 2002-04-25
ZA200006768B (en) 2001-11-20
ES2173739T3 (es) 2002-10-16
CA2333188C (fr) 2010-07-06
NO20005838D0 (no) 2000-11-17
NO20005838L (no) 2001-01-10
CA2333188A1 (fr) 1999-11-25
HK1033271A1 (en) 2001-08-24
WO1999059557A1 (fr) 1999-11-25
CN1305371A (zh) 2001-07-25
PT1077687E (pt) 2002-09-30
EP1077687A1 (fr) 2001-02-28

Similar Documents

Publication Publication Date Title
CN102970983B (zh) 耐受酒精的口服药物制剂
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
US5670172A (en) Pharmaceutical spheroid formulation
US6039979A (en) Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
KR101632368B1 (ko) 미소 과립을 함유하는 알코올 저항성 서방형 경구 의약 제형
JPH0611699B2 (ja) 固体薬剤調製物及びその製造法
JP2003504324A (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
JP2002515423A (ja) プログラム放出性及びパルス放出性の多微粒子薬剤形態、及びその調製方法
JP2002501895A (ja) 胃において保護されるオメプラゾール微粒子、その製造方法および医薬製剤
JP2004521910A (ja) トラマドール系薬剤
JP2009537611A (ja) リポ酸の丸薬
JP2003502360A (ja) トラマドールとジクロフェナクの固定組合せ物を投与するための経口投与形
JP2000510488A (ja) 改良投薬ユニット
JP4447166B2 (ja) 硫酸モルヒネマイクロ顆粒剤、製法および医薬調製物
JP2001517625A (ja) 活性成分放出制御薬物製剤
JP4296562B2 (ja) 硫酸モルヒネ微小顆粒、その調製方法およびそれを含有する組成物
JP2002537323A (ja) ロラタジン及びプソイドエフェドリンを含有する医薬カプセル組成物
JPH04234812A (ja) 持続性製剤用顆粒
JP2001503398A (ja) 複数の連続する制御された放出を持った多粒子製薬形態の調製方法
US9877925B2 (en) Alcohol-resistant oral pharmaceutical form
KR20020031421A (ko) 경구 투여 형태
HK1033271B (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
HK1160402A (en) Oral pharmaceutical form based on microgranulates with prolonged release resistant to alcohol

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090804

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20091026

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091208